Main Category: Pancreatic Cancer
Also Included In: Cancer / Oncology
Article Date: 25 Oct 2012 – 12:00 PDT
Pancreatic Cancer Discovery Offers New Hope For Patients
A set of mutated genes responsible for causing pancreatic cancer have been discovered by Australian researchers and revealed in a new study published in the journal Nature.
This is the first time a collaboration of the world’s ideal experts has been carried out to determine the genetic factors that influence 50 different types of cancer.
According to the report, pancreatic cancer accounts for more deaths than any other major type of cancer. Survival rates have not improved over the last 40 years, acting as the fourth-leading cause of death from cancer. Common symptoms of pancreatic cancer include:
NauseaVomiting Appetite Loss Pain in the upper part of the stomach (abdomen), which can spread to the backUnusual weight lossDiabetes mellitus or high levels of blood sugarDepression Trosseau sign (when blood clots pop up out of nowhere in the deep veins of a person’s extremities, superficial veins anywhere on the body, or in the portal blood vesselsExperts noted that early pancreatic cancer sometimes does not come with any symptoms what-so-ever. According to previous research, pancreatic cancer patients’ lives can be saved if they visit more experienced hospitals and facilities.
The international team of more than 100 researchers was led by Professor Sean Grimmon, from the Institute for Molecular Bioscience (IMB) at The University of Queensland, and Professor Andrew Biankin from The Kinghorn Cancer Centre at Garvan Institute of Medical Research / St. Vincent’s Hospital in Sydney.
The experts sequenced the genomes from 100 pancreatic tumors and examined them in comparison with non-cancerous tissue to discover which genetic alterations may have caused the cancer.
“We found over 2,000 mutated genes in total, ranging from the KRAS gene, which was mutated in about 90 per cent of samples, to hundreds of gene mutations that were only present in 1 or 2 per cent of tumors. So while tumors may look very similar under the microscope, genetic analysis reveals as many variations in each tumor as there are patients. This demonstrates that so-called ‘pancreatic cancer’ is not one disease, but many, and suggests that people who seemingly have the same cancer might be to be treated quite differently.”
Biankin commented that in the future, independent diagnoses and treatment plans for each patient will be the “norm”. He said, “In this study, we found a set of genes, the axon guidance pathway, that is frequently damaged in pancreatic cancer patients and is associated with potentially poorer outcomes for those patients. It is a new marker of pancreatic cancer that can be used to direct prognoses and treatments.”
Biankin continued: “‘Personalized medicine’, where the molecular profile of a patient is matched to the ideal treatment, is the way the world is moving for many diseases, not just cancer. The challenge now will be moving from population health-care and a ‘one drug fits all’ model to personalized healthcare. First, we must take the time to develop the necessary genetic knowledge and implement health systems to translate that knowledge effectively.”
The Professors noted that the Australian Pancreatic Cancer Genome Initiative, which involves over 20 hospitals and research facilities, of more than 200 nurses, surgeons, pathologists, and experts, played a massive part in their study.
Professor Warwick Anderson, from the National Health and Medical Research Council of Australia, which funded the study with a $27.5 million grant, said: “NHMRC is proud to have been the major funding contributor to this research, and I am delighted that breakthroughs have been made in understanding the genetic basis of this disease. This positive outcome is evidence of NHMRC supporting the very ideal research and researchers, and the importance of our involvement in strong national and international collaborations. The ultimate goal of our funding is healthier citizens, both in Australia and overseas, and this research will certainly lead to a better comprehend of this issue.”
Not to be reproduced without permission of Medical News Today
Visit our pancreatic cancer section for the latest news on this subject. “Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes”Andrew Biankin, Sean Grimmon, et.al.
Nature, October 2012, doi: 10.1038/nature11547 Please use one of the following formats to cite this article in your essay, paper or report:
n.p. “Pancreatic Cancer Discovery Offers New Hope For Patients.” Medical News Today. MediLexicon, Intl., 25 Oct. 2012. Web.
Please note: If no author information is provided, the source is cited instead.
‘Pancreatic Cancer Discovery Offers New Hope For Patients’
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
- Existing Breast Cancer Drugs May Help More Women
- Diabetes Drug Metformin May Fight Cancer
- Target Meeting’s 2nd World Cancer Online Conference Held On January 8-11, 2013: Join For Free
- Scientists Find Biomarker That Can Improve Breast Cancer Therapy
- Data shows association between increased weight and breast cancer survival varies by race/ethnicity
- Epigenetic difference in twins explains different risk of breast cancer
- Sex Lives of Patients Probed to Fight Oral Cancer
- Superior Cancer Screening?
- Cancer research yields unexpected new way to produce nylon
- Cancer research yields unexpected new way to produce nylon
Submited at Friday, October 26th, 2012 at 12:15 am on Uncategorized by samantha
Comment RSS 2.0 - leave a comment - trackback